A.I. Cancer Drugmaker Meeting with Big Pharma Companies

Live Interview with Cheddar (1/4/2020):  Niven dives into BERG’s two potential drug products moving towards Phase III development and other late stage assets in planning phases, the future of AI within discovery, and partnering with big pharma companies to improve patient outcomes.  Click HERE for the interview.